HEADER TRANSFERASE/IMMUNE SYSTEM 18-AUG-17 5Y80 TITLE COMPLEX STRUCTURE OF CYCLIN G-ASSOCIATED KINASE WITH GEFITINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLIN-G-ASSOCIATED KINASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 25-335; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: NANOBODY; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GAK; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: LAMA GLAMA; SOURCE 11 ORGANISM_TAXID: 9844; SOURCE 12 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 14 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS KINASE, COMPLEX, TRANSFERASE-IMMUNE SYSTEM COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.OHBAYASHI,K.MURAYAMA,M.KATO-MURAYAMA,M.SHIROUZU REVDAT 4 23-OCT-24 5Y80 1 REMARK REVDAT 3 22-NOV-23 5Y80 1 REMARK REVDAT 2 07-NOV-18 5Y80 1 JRNL REVDAT 1 29-AUG-18 5Y80 0 JRNL AUTH N.OHBAYASHI,K.MURAYAMA,M.KATO-MURAYAMA,M.KUKIMOTO-NIINO, JRNL AUTH 2 T.UEJIMA,T.MATSUDA,N.OHSAWA,S.YOKOYOMA,H.NOJIMA,M.SHIROUZU JRNL TITL STRUCTURAL BASIS FOR THE INHIBITION OF CYCLIN G-ASSOCIATED JRNL TITL 2 KINASE BY GEFITINIB. JRNL REF CHEMISTRYOPEN V. 7 721 2018 JRNL REFN ESSN 2191-1363 JRNL PMID 30214852 JRNL DOI 10.1002/OPEN.201800177 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.11.1-2575_743) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.92 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 17740 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.232 REMARK 3 R VALUE (WORKING SET) : 0.230 REMARK 3 FREE R VALUE : 0.282 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.360 REMARK 3 FREE R VALUE TEST SET COUNT : 951 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.9310 - 4.7808 1.00 2509 168 0.1907 0.2293 REMARK 3 2 4.7808 - 3.7953 1.00 2407 143 0.1907 0.2075 REMARK 3 3 3.7953 - 3.3157 1.00 2375 145 0.2663 0.3463 REMARK 3 4 3.3157 - 3.0126 1.00 2380 138 0.2707 0.3264 REMARK 3 5 3.0126 - 2.7968 1.00 2402 96 0.2639 0.3662 REMARK 3 6 2.7968 - 2.6319 1.00 2344 129 0.2625 0.3669 REMARK 3 7 2.6319 - 2.5001 1.00 2372 132 0.2558 0.3549 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.350 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.490 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 3549 REMARK 3 ANGLE : 1.094 4796 REMARK 3 CHIRALITY : 0.039 514 REMARK 3 PLANARITY : 0.003 615 REMARK 3 DIHEDRAL : 20.230 1328 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5Y80 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 25-AUG-17. REMARK 100 THE DEPOSITION ID IS D_1300003999. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-OCT-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL32XU REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-225 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17801 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 47.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 9.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.60 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 9.90 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4C57 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.48 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM SULFATE,0.1 M SODIUM REMARK 280 CACODYLATE TRIHYDRATE (PH 6.5), 15% PEG 8000, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 35.16550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.65550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.93500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 47.65550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.16550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.93500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 23 REMARK 465 GLU A 138 REMARK 465 SER A 139 REMARK 465 ARG A 140 REMARK 465 GLU A 333 REMARK 465 GLN A 334 REMARK 465 ASN A 335 REMARK 465 GLY B -6 REMARK 465 SER B -5 REMARK 465 SER B -4 REMARK 465 GLY B -3 REMARK 465 SER B -2 REMARK 465 SER B -1 REMARK 465 ALA B 124 REMARK 465 ALA B 125 REMARK 465 TYR B 126 REMARK 465 PRO B 127 REMARK 465 TYR B 128 REMARK 465 ASP B 129 REMARK 465 VAL B 130 REMARK 465 PRO B 131 REMARK 465 ASP B 132 REMARK 465 TYR B 133 REMARK 465 GLY B 134 REMARK 465 SER B 135 REMARK 465 HIS B 136 REMARK 465 HIS B 137 REMARK 465 HIS B 138 REMARK 465 HIS B 139 REMARK 465 HIS B 140 REMARK 465 HIS B 141 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O TYR B 60 NZ LYS B 65 2.18 REMARK 500 NH2 ARG A 43 OE2 GLU B 53 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B 111 C - N - CA ANGL. DEV. = 9.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 172 -10.18 68.73 REMARK 500 ARG A 259 16.16 59.68 REMARK 500 TYR A 285 43.30 -102.01 REMARK 500 LEU A 296 58.14 -90.22 REMARK 500 ASP B 31 46.38 -108.64 REMARK 500 SER B 55 18.29 59.72 REMARK 500 ARG B 99 179.33 63.34 REMARK 500 SER B 122 42.82 -91.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue IRE A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue IRE A 402 DBREF 5Y80 A 25 335 UNP O14976 GAK_HUMAN 25 335 DBREF 5Y80 B -6 141 PDB 5Y80 5Y80 -6 141 SEQADV 5Y80 GLY A 23 UNP O14976 EXPRESSION TAG SEQADV 5Y80 SER A 24 UNP O14976 EXPRESSION TAG SEQRES 1 A 313 GLY SER GLN SER ASP PHE VAL GLY GLN THR VAL GLU LEU SEQRES 2 A 313 GLY GLU LEU ARG LEU ARG VAL ARG ARG VAL LEU ALA GLU SEQRES 3 A 313 GLY GLY PHE ALA PHE VAL TYR GLU ALA GLN ASP VAL GLY SEQRES 4 A 313 SER GLY ARG GLU TYR ALA LEU LYS ARG LEU LEU SER ASN SEQRES 5 A 313 GLU GLU GLU LYS ASN ARG ALA ILE ILE GLN GLU VAL CYS SEQRES 6 A 313 PHE MET LYS LYS LEU SER GLY HIS PRO ASN ILE VAL GLN SEQRES 7 A 313 PHE CYS SER ALA ALA SER ILE GLY LYS GLU GLU SER ASP SEQRES 8 A 313 THR GLY GLN ALA GLU PHE LEU LEU LEU THR GLU LEU CYS SEQRES 9 A 313 LYS GLY GLN LEU VAL GLU PHE LEU LYS LYS MET GLU SER SEQRES 10 A 313 ARG GLY PRO LEU SER CYS ASP THR VAL LEU LYS ILE PHE SEQRES 11 A 313 TYR GLN THR CYS ARG ALA VAL GLN HIS MET HIS ARG GLN SEQRES 12 A 313 LYS PRO PRO ILE ILE HIS ARG ASP LEU LYS VAL GLU ASN SEQRES 13 A 313 LEU LEU LEU SER ASN GLN GLY THR ILE LYS LEU CYS ASP SEQRES 14 A 313 PHE GLY SER ALA THR THR ILE SER HIS TYR PRO ASP TYR SEQRES 15 A 313 SER TRP SER ALA GLN ARG ARG ALA LEU VAL GLU GLU GLU SEQRES 16 A 313 ILE THR ARG ASN THR THR PRO MET TYR ARG THR PRO GLU SEQRES 17 A 313 ILE ILE ASP LEU TYR SER ASN PHE PRO ILE GLY GLU LYS SEQRES 18 A 313 GLN ASP ILE TRP ALA LEU GLY CYS ILE LEU TYR LEU LEU SEQRES 19 A 313 CYS PHE ARG GLN HIS PRO PHE GLU ASP GLY ALA LYS LEU SEQRES 20 A 313 ARG ILE VAL ASN GLY LYS TYR SER ILE PRO PRO HIS ASP SEQRES 21 A 313 THR GLN TYR THR VAL PHE HIS SER LEU ILE ARG ALA MET SEQRES 22 A 313 LEU GLN VAL ASN PRO GLU GLU ARG LEU SER ILE ALA GLU SEQRES 23 A 313 VAL VAL HIS GLN LEU GLN GLU ILE ALA ALA ALA ARG ASN SEQRES 24 A 313 VAL ASN PRO LYS SER PRO ILE THR GLU LEU LEU GLU GLN SEQRES 25 A 313 ASN SEQRES 1 B 148 GLY SER SER GLY SER SER GLY GLN VAL GLN LEU GLN GLU SEQRES 2 B 148 SER GLY GLY GLY LEU VAL GLN PRO GLY GLY SER LEU ARG SEQRES 3 B 148 LEU SER CYS SER ALA SER GLY PHE LYS PHE ASN ASP SER SEQRES 4 B 148 TYR MET SER TRP VAL ARG ARG VAL PRO GLY LYS GLY LEU SEQRES 5 B 148 GLU TRP VAL ALA GLY ILE TRP GLU ASP SER SER ALA ALA SEQRES 6 B 148 HIS TYR ARG ASP SER VAL LYS GLY ARG PHE THR ILE SER SEQRES 7 B 148 ARG ASP ASN ALA LYS ASN MET LEU TYR LEU GLN MET SER SEQRES 8 B 148 SER LEU LYS SER ASP ASP THR GLY LEU TYR TYR CYS VAL SEQRES 9 B 148 ARG ARG GLY TYR SER GLY ASP TYR ARG PRO ILE ASN ASN SEQRES 10 B 148 PRO SER SER GLN GLY THR GLN VAL THR VAL SER SER ALA SEQRES 11 B 148 ALA ALA TYR PRO TYR ASP VAL PRO ASP TYR GLY SER HIS SEQRES 12 B 148 HIS HIS HIS HIS HIS HET IRE A 401 31 HET IRE A 402 31 HETNAM IRE GEFITINIB FORMUL 3 IRE 2(C22 H24 CL F N4 O3) FORMUL 5 HOH *60(H2 O) HELIX 1 AA1 GLU A 75 LEU A 92 1 18 HELIX 2 AA2 LEU A 130 LYS A 136 1 7 HELIX 3 AA3 SER A 144 ARG A 164 1 21 HELIX 4 AA4 LYS A 175 GLU A 177 5 3 HELIX 5 AA5 SER A 207 ARG A 220 1 14 HELIX 6 AA6 THR A 223 ARG A 227 5 5 HELIX 7 AA7 THR A 228 ASP A 233 1 6 HELIX 8 AA8 GLU A 242 ARG A 259 1 18 HELIX 9 AA9 ALA A 267 ASN A 273 1 7 HELIX 10 AB1 TYR A 285 VAL A 287 5 3 HELIX 11 AB2 PHE A 288 LEU A 296 1 9 HELIX 12 AB3 ASN A 299 ARG A 303 5 5 HELIX 13 AB4 SER A 305 ALA A 319 1 15 HELIX 14 AB5 LYS B 28 SER B 32 5 5 HELIX 15 AB6 ASP B 62 LYS B 65 5 4 HELIX 16 AB7 LYS B 87 THR B 91 5 5 SHEET 1 AA1 6 THR A 32 LEU A 35 0 SHEET 2 AA1 6 LEU A 38 ALA A 47 -1 O LEU A 40 N VAL A 33 SHEET 3 AA1 6 ALA A 52 ASP A 59 -1 O GLU A 56 N ARG A 43 SHEET 4 AA1 6 GLU A 65 LEU A 72 -1 O LEU A 68 N TYR A 55 SHEET 5 AA1 6 GLU A 118 GLU A 124 -1 O LEU A 121 N LYS A 69 SHEET 6 AA1 6 PHE A 101 ILE A 107 -1 N ALA A 105 O LEU A 120 SHEET 1 AA2 3 GLY A 128 GLN A 129 0 SHEET 2 AA2 3 LEU A 179 LEU A 181 -1 O LEU A 181 N GLY A 128 SHEET 3 AA2 3 ILE A 187 LEU A 189 -1 O LYS A 188 N LEU A 180 SHEET 1 AA3 4 GLN B 5 SER B 7 0 SHEET 2 AA3 4 LEU B 18 SER B 23 -1 O SER B 21 N SER B 7 SHEET 3 AA3 4 MET B 78 MET B 83 -1 O MET B 83 N LEU B 18 SHEET 4 AA3 4 PHE B 68 ASP B 73 -1 N THR B 69 O GLN B 82 SHEET 1 AA4 6 GLY B 10 VAL B 12 0 SHEET 2 AA4 6 THR B 116 VAL B 120 1 O THR B 119 N VAL B 12 SHEET 3 AA4 6 GLY B 92 ARG B 98 -1 N GLY B 92 O VAL B 118 SHEET 4 AA4 6 MET B 34 VAL B 40 -1 N VAL B 37 O TYR B 95 SHEET 5 AA4 6 GLY B 44 ILE B 51 -1 O ALA B 49 N TRP B 36 SHEET 6 AA4 6 ALA B 58 TYR B 60 -1 O HIS B 59 N GLY B 50 SHEET 1 AA5 2 TYR B 101 SER B 102 0 SHEET 2 AA5 2 ARG B 106 PRO B 107 -1 O ARG B 106 N SER B 102 SSBOND 1 CYS B 22 CYS B 96 1555 1555 2.03 CISPEP 1 LYS A 166 PRO A 167 0 -2.77 SITE 1 AC1 12 LEU A 46 ALA A 67 LYS A 69 GLU A 85 SITE 2 AC1 12 GLU A 124 CYS A 126 LYS A 127 GLY A 128 SITE 3 AC1 12 GLN A 129 LEU A 180 HOH A 517 HOH A 521 SITE 1 AC2 12 ALA A 81 ARG A 172 GLY A 193 SER A 194 SITE 2 AC2 12 HIS A 200 VAL A 214 ASN A 221 THR A 222 SITE 3 AC2 12 ILE A 240 GLN A 244 HOH A 524 HOH A 533 CRYST1 70.331 73.870 95.311 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014218 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013537 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010492 0.00000